By Mark Hay | April 13, 2020

Heather Kilpatrick has been busy lately. Since the United States began sliding into COVID-19 lockdown mode, the operations manager for at-home sperm collection firm CryoChoice says the company has “seen a lot of inquiries come in from people scared about coronavirus.” But rather than just checking in or canceling orders, many of them seem to want to make purchases.

According to Kilpatrick, CryoChoice has seen sales jump by as much as 20 percent in recent weeks. Staff at the at-home sperm collection start-up Legacy claim they’ve seen up to 10 times their usual order volume in recent days. And the minds behind Dadi, another start-up in the field, say they have not only seen a threefold lift in raw sales, but that more people than ever before are buying five years of sperm storage up front.

To read the full article visit